No way! But... [Design Issues]

posted by Beholder  – Russia, 2019-12-06 11:36 (523 d 14:56 ago) – Posting: # 20940
Views: 4,095

(edited by Beholder on 2019-12-06 12:06)

Dear ssussu!

» At this situation, should this subject's data with one period be included in the BE assessment?

No, you could not.

» Why?

Because you need comparison between T and R for each subject. This is the aim - to compare. In your case you have either T or R (I dont know exactly which drug was taken on period 2). At least, you could use Cmax value from period 2 if the subject withdraw after Cmax was reached. AUC - no way.

Best regards
Beholder

Complete thread:

Activity
 Admin contact
21,457 posts in 4,485 threads, 1,512 registered users;
online 12 (0 registered, 12 guests [including 4 identified bots]).
Forum time: Thursday 02:33 UTC (Europe/Vienna)

Nothing in the world is more dangerous
than sincere ignorance
and conscientious stupidity.    Martin Luther King, Jr.

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5